Biology of Fracture Healing Flashcards
osteoporosis
loss of bone bass, often associated with menopause and/or aging
who does osteoporosis affect
women and men
osteoporosis is a major medical problem due to (3)
aging population, diet, environmental factors
Osteoporosis definition -
a patient with a BMD
>2.5 standard deviations below average for a
healthy young female or male.
those with osteoporosis have an increased susceptibility to
fracture
causes ?8.9 million fractures annually
Worldwide, — women and — men over 50
will experience osteoporotic fractures
1 in 3
1 in 5
Hip fractures associated with mortality rates of up
to
20-24% in first year after fracture. Greater risk
of dying may persist for at least 5 years
In Osteoporosis Bone Formation Can’t Keep up
With
Bone Destruction and we Lose Bone (Remo
Oral bisphosphonates widely used for treatment of
osteoporosis
anti-resorptives
I.V. bisphosphonates used for treatment of
particularly if…
myeloma/ bone metastatic cancers (e.g. breast, prostate, lung),
particularly if patients have high serum calcium
Doses used for — treatment often much higher than those used for —
cancer
osteoporosis
Bisphosphonates =
non-hydrolyzable analogs of
pyrophosphate (PPi) – inhibit mineralization similarly to PPi
bisphosphinates have a high affinity for
hydroxyapatite
BONJ
Bisphosphonate Associated Osteonecrosis of the Jaw
Vast majority in patients with myeloma/bone metastatic cancers on
i.v. bisphosphonates (esp. zoledronate and other N-containing BP’s)
Prevalence = –% in cancer population on BPs
2-3
Prevalence in oral BP (osteoporosis patients) = –%
0.1-0.5
BONJ affects the (2)
maxilla or mandible
BONJ definition (American Association of Oral and Maxillofacial Surgeons [AAOMS]): (3)
(1) current or previous treatment with a bisphosphonate
(2) exposed, necrotic bone in the maxillofacial region that has been
present for at least 8 weeks
(3) no history of radiation therapy to the jaws
BONJ Pathogenesis
Not fully understood, but attributed mainly to suppression
of bone turnover due to BP inhibition of osteoclast activity
With osteoclast inhibition, bone may be unable to
repair in response to trauma
BPs may also have — effects on epithelia
inhibitory
Bisphosphonates may also have an inhibitory effect on
orthodontic tooth movement
Bone formation during fracture healing recapitulates processes of
embryonic bone formation
Four Phases of Skeletal Development
- Migration of preskeletal cells to sites of future
skeletogenesis - Interaction of these cells with epithelial cells
- Interaction leads to mesenchymal condensation
- Followed by differentiation to chondroblasts or
osteoblasts
Endochondral Bone Formation is —
indirect
Indirect in endochondral bone formation because
mesenchyme forms cartilage template first, which is later replaced by bone
where does endochondral bone formation occur?
in most bones in the skeleton
esp bones that ear weight and have joints
endochondral bone formation also occurs during
fracture repair
Intramembranous Bone Formation is —
direct
intramembranous bone formation is direct because it involves
transformation of mesenchymal cells to osteoblasts (no cartilage intermediate)
where does intramembranous bone formation occur? (3)
restricted to cranial vault, some facial bones, parts of the mandible and clavicle
intramembranous bone formation contributes to
fracture repair
in endochondral bone formation (typically long bone)
Growth plate fusion occurs around age —
in humans depending on the (2)
14-20
specific bone and the gender of the individual
in endochondral bone formation (typically long bone)
Vascular endothelial growth factor (VEGF) produced by hypertrophic chondrocytes attracts
blood vessels that invade the cartilage model
in endochondral bone formation (typically long bone)
Secondary ossification center appears around the time of —
birth
in intramembranous bone formation, mesenchymal cells condense to produce —, which
osteoblasts deposit osteoid (unmineralized) bone matrix
in intramembranous bone formation, osteoid matrix calcifies/osteoblasts become arranged along
calcified region of the
matrix
some osteoblasts trapped in bone matrix, which become
osteocytes
First type of bone produced developmentally =
Woven Bone (a.k.a. Primary Bone) (immature)
when is woven bone produced?
when osteoblasts need to form bone rapidly
examples of when woven bone is formed (3)
embryonic development
fracture healing
disease states (ex pagets disease)
Immature woven bone then remodeled and replaced with
Lamellar Bone (a.k.a. Secondary Bone) (mature)
woven bone (4)
•Disorganized structure •Collagen fibrils in random orientation (lower birefringence w/ polarized light) •Increased cell density •Reduced mineral content
lamellar bone (4)
•Highly organized •Bone lamellae concentrically arranged around central canal (Haversian canal) containing blood vessels, nerves. •Collagen fibrils in parallel orientation (more birefringence w/ polarized light) •Mechanically stronger
Secondary bone = further classified into (2)
Compact (cortical) Bone and Cancellous (trabecular/spongy) Bone
Compact
cortical/
Haversian
Cancellous
spongy/
trabecular
Skeletal healing essential for: (3)
•Resolution of orthopedic trauma that has
caused fractures
•Healing of corrective surgeries where bony
injuries are created intentionally to correct
bone deformities, etc
•Bone regeneration in oral surgical
procedures/tooth extractions, etc.
Development of new treatments to promote healing of (3)
fibrous non-unions,
critically sized defects,
conditions of impaired healing.
Failed/delayed healing affects up to –% of
fracture patients seen clinically
10
Can result from inadequate (6)
fixation, infection, tumor, hypoxia/poor blood supply, metabolic dysfunction, chronic diseases/inherited diseases
Fracture Healing Requires Coordinated
Activity of Several Cell Types: (5)
- Inflammatory Cells
- Chondroprogenitors/chondrocytes
- Osteoprogenitors/osteoblasts
- Osteoclasts
- Vascular cells
Inflammatory (Reactive) phase:
peaks by 48h and is
diminished by 1 week
Reparative phase:
activated within a few
days and persists for
up to 2-3 months
Remodeling phase:
can continue for
several years
John Hunter (1935) - Described 4 stages of fracture repair:
reactive: 1) Formation of vascular hematoma
reparative: 2) Formation of (fibrocartilage)
callus
repairative: 3) Tissue metaplasia – callus
replaced by mineralized bone
remodeling: 4) Bone remodeling and turnover
Fracture trauma causes
bleeding/formation of hematoma at injury site
Hematoma-associated cytokines
released: (2)
Tumor necrosis factor-α (TNF-α )
Interleukins (IL-1,-6, -11 and -18)
Cytokines lead to recruitment/infiltration
of
inflammatory cells
Inflammatory cells release more — and recruit — to fracture site
inflammatory cytokines
mesenchymal stem cells (MSC)/osteogenic precursors
Hematoma Formation/Inflammation occurs within
0-2 days
MSC/connective tissue stem cells/blood
vessels invade —
hematoma
Hematoma —/Phagocytes
clear —
degenerates
debris
Fibrous connective tissue matrix laid
down by
fibroblasts (granulation tissue)
Some MSC differentiate toward — lineages
chondrogenic/osteogenic
At broken ends of bones where blood
supply was disrupted — occurs
hypoxia/ tissue necrosis
In hypoxic regions MSC differentiate into
— which initiates —
chondrocytes
endochondral bone formation
Intramembranous bone may form in
subperiosteal sites where vascular supply
is intact =
hard (external) callus
formation of fibrocartilagenous callus takes
~1 week
Cell sources (4)
- Periosteum
- Muscle
- Bone Marrow
- Circulating?
Cell types (3)
- Mesenchymal Stem Cell (MSC)
- Pericyte
- Muscle satellite cell
Intramembranous bone (formed where vascular supply intact) contributes to
bony
callus
Cartilage undergoes — —
endochondral
ossification
endochondral
ossification
hypertrophy>calcification of
cartilage>removal by osteoclasts>
replacement with bone
Fracture considered healed when
bone stability restored by bone tissue
completely bridging the original fracture
(“clinical union”)
Initial bone formed =
woven bone
Formation of Bony Callus takes
~several weeks up to 2-3 months
Initial woven bone must be —
remodeled
Osteoclasts resorb woven bone in
fracture callous then osteoblasts lay
down new lamellar bone (Haversian) =
mechanically stronger
remodeling restores
marrow cavity
remodeling resortes
original contours of bone
Biomechanical stability matches that of
the — bone
original
Same sequence of fracture healing events
occurs for
healing of alveolar bone in
tooth socket after tooth extraction
remodeling takes
~several weeks/months/years
Gene expression profiles/signaling molecules important during
fracture healing
Fracture healing includes (4)
inflammation,
endochondral bone formation,
intramembranous bone formation,
osteoclastic bone resorption
Gene expression profile =
— dependent
reflective of these —
stage dependent
and reflective of these processes
Early Phases of Fracure Healing Include: (5)
- Formation of hematoma
- Recruitment of MSC
- Cell proliferation
- Initiation of chondrogenesis/osteogenesis
- Vascular ingrowth/angiogenesis
Signaling Molecules Important in
Fracture Healing:
3 Main categories:
- Pro-inflammatory cytokines
- TGFβ superfamily members
- Angiogenic factors
pro-inflammatory cytokines (4)
− Recruit other inflammatory cells/ promote MSC
recruitment
− Induce apoptosis of hypertrophic chondrocytes
− Recruit fibrogenic cells/promote formation of
granulation tissue/ECM formation
− Can promote osteoclast formation
pro inflammatory cytokines are secreted by (3)
macrophages,
mesenchymal cells,
inflammatory cells
Mice null for TNF-α receptor show impaired
fracture healing
Pro-Inflammatory Cytokines (2)
Tumor necrosis factor-α (TNF-α)
Interleukins (IL-1,-6, -11 and -18)
TGFβ Superfamily Members (3)
Transforming growth factor-β (TGFβ)
Bone morphogenetic protein-2 BMP2 (also 5,6)
Growth and differentiation factor-8 (GDF-8)
TGFβ Superfamily Members promote (3)
− Promote ECM synthesis & assembly/initiation of callus formation
− Promote osteogenic differentiation
− GDF-8 – role in cell proliferation
TGFβ Superfamily Members produced by (4)
hematoma (platelets)/
granulation tissue/
differentiating MSC/
periosteal callus
angiogenic factors (3)
VEGF - Vascular endothelial growth factor
PDGF - Platelet derived growth factor
ANGPT - Angiopoietin
Promote vascular ingrowth from vessels in
periosteum (brings oxygen/osteogenic precursors [pericytes])
VEGF:
−promotes — of osteoprogenitors
−upregulated in regions of — (under control of
transcription factor HIF1α)
−— overexpressing mice show enhanced bone
regeneration (Wan et al 2008: PNAS 105:686-91)
chemotaxis
hypoxia
HIF1α
Vascularization is critical for
fracture repair/bone formation
vascularization brings in (2) for mineralization
calcium and phosphate
Factors regulating other aspects of fracture
healing: (3)
- Osteoblastic bone formation
- Osteoclastic bone resorption
- Cartilage formation
Fracture stability (mechanical environment) dictates the type of — that will occur
healing
— — determines mechanical strain in fracture site
Mechanical stability
If strain <2% — — — will occur
intramembranous bone healing
If strain is >2% <10% — — — will occur
endochondral bone healing
High strain >15% promotes — —
fibrous tissue
Healing may occur as combination of the above processes depending on
stability throughout the fracture healing process
Important to stabilize fracture, but still have some strain on the bone, as zero mechanical loading can
delay healing
Bone Repair Could be Enhanced by: (4)
- Improving vascularization
- Attracting progenitor cells
- Accelerating bone formation
- Accelerating remodeling
BMPs (recombinant) are evaluated in
preclinical and clinical trials
BMPs appear to be an effective alternative to
autologous bone graft for repair of fracture non union/open tibial fractures
Controversy about clinical use of BMPs due to (2)
cost
effectiveness and potential safety drawbacks
Platelet Rich Plasma contains
multiple growth factors
Platelet Rich Plasma is evaluated in
preclinical and clinical trials
Platelet Rich Plasma also appears to be effective in
promoting bone healing
FGF signaling also important in (2)
skeletal development/fracture healing
— – shown to enhance
fracture healing in various in vivo experiments
dating back to 1990s
FGF2 (a.k.a. basic FGF)
But – continued elevation of FGF2 may impair
mineralization, so — of treatment needs to be
optimized
timing
— is also promising in preclinical studies
PDGF
cell based therapies (2)
Autologous bone marrow
Purified stem cell sources (MSC-mesenchymal
stem cells, EPC - endothelial progenitor cells)
Combining these growth factors with — — — may lead to further improvements
tissue engineering techniques
cell based therapies (2)
Autologous bone marrow
Purified stem cell sources (MSC-mesenchymal
stem cells, EPC - endothelial progenitor cells)
Autologous bone marrow – collected from
iliac crest/injected into non-union site (increases #
of progenitor cells)
cell based therapies (2)
Autologous bone marrow
Purified stem cell sources (MSC-mesenchymal
stem cells, EPC - endothelial progenitor cells)
other approaches (3)
- Anti-resorptives (bisphosphonates, denosumab)
- Bone anabolic agents (sclerostin Abs, teriparitide)
- (Gene therapy) – [still experimental]
Sclerostin =
inhibitor of Wnt/β-catenin signaling
important pathway for bone formation
Antibodies to sclerostin being developed as
anabolic treatment for osteoporosis (in clinical
trials)
sclerotin is also evaluated in
fracture healing preclinical models – results very promising
sclerostin Abs enhanced bone regeneration in rat model of —
periodontitis